期刊文献+

内皮素-1(ET-1)在口腔粘膜下纤维性变中的表达水平 被引量:3

The Expression of Endothelin 1 (ET 1) in Oral Submucous Fibrosis
原文传递
导出
摘要 为探讨ET-1与口腔粘膜下纤维性变(OSF)的关系,应用免疫组化染色和图像分析技术,检测了OSF30例、正常口腔粘膜(NOR)10例组织中ET-1的定位分布和含量。结果显示:①OSF组织中ET-1有异常表达,其免疫阳性物质主要分布于上皮棘细胞、基底细胞,间质成纤维细胞、血管内皮细胞及平滑肌细胞的胞浆胞膜上;②ET-1在OSF组织表达的阳性率及相对含量均显著高于NOR(P<0.01);③OSF各期ET-1相对含量存在差别,其中早、中期上皮细胞ET-1相对含量显著高于晚期(P<0.05)。由此提示。 WT5”BZ〗In order to urderstand whether ET 1 is involved in the pathology of oral submucous fibrosis (OSF),a sensitive immuno histochemical and morphometric technique was adopted in the examination of the localization and content of ET 1 in oral mucosa from 30 patients with OSF, 10 normal oral mucosa. The results showed that:(1) Overexpression of ET 1 showed in mucosa from OSF, the immunostains for ET 1 were prominent within the cytoplasm and on the cell membrane of spinocells, basiocells,fibroblasts, vascular endothelial and smooth muscle cells.(2) The proportion of ET 1 positive cells and the cellular content of ET 1 in OSF was all significantly higher than that in normal control ( P <0.01);(3) Difference exists between early, moderate and advanced stages OSF, while the cell contents of ET 1 in early and moderate stages were significantly higher than that in advanced stage in epithelium ( P <0.05). ET 1 conld play a role in the fibrogenic process of OSF.
出处 《临床口腔医学杂志》 1999年第1期41-44,共4页 Journal of Clinical Stomatology
关键词 内皮素-1 口腔粘膜 纤维性变 形态计量学 Endothelin 1 Oral submucous fibrosis Morphometry
  • 相关文献

参考文献1

二级参考文献1

  • 1倪灿荣,免疫组织化学实验新技术及应用,1993年,131页

共引文献10

同被引文献28

  • 1高义军,凌天牖,吴汉江,李运良.口腔粘膜下纤维性变组织中转化生长因子β_1mRNA表达水平[J].华西口腔医学杂志,1996,14(1):20-22. 被引量:6
  • 2Reichart PA, Van Wyk CW, Becker J, et al. Distribution of procollagen type Ⅲ, collagen type VI and tenascin in oral submucous fibrosis (OSF) [J]. J Oral Pathol Med, 1994, 23 (9) : 394-398.
  • 3Kawaguchi Y, Suzukik K, Hara H,et al.Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis[J] .Ann Rheum Dis, 1994,53 (38) : 506-510.
  • 4Haque MF, Harris M, Meghji S, et al. Immunolocalization of cytokines and growth factors in oral submucous fibrosis [J]. Cytokine,1998, 10(9) :713-719.
  • 5胥红 刘蜀凡 沈子华 等.口腔黏膜下纤维性变组织中V型胶原和纤维连结蛋白的免疫组化及定量分析[J].中华口腔医学杂志,1999,34(5):283-283.
  • 6Phatak AG.Oral submucous fibrosis a chronic dissemination in travascular coagulation syndrome with local coagulpathy [J]. Gut,1993, 34(5) :71-73.
  • 7Zhang LP, Takahara T, Yata Y, et al. Increased expression of plasminogen activator and plasminogen activators inhibitor during during liver fibrogenesis of rats: role of stellate cells [J]. Journal of Hepatology 1999, 31 (4) : 703-711.
  • 8Yang SF, Hsieh YS, Tsai CH, et al. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis [J].Oral Oncol, 2003,39 (4) : 367-372.
  • 9C P Chiang, H Y Wu, B Y Liu, et al. Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan [J]. Oral Oncology, 2002,38 (1) : 56-63.
  • 10Sharma JK, Gupta AK, Mukhija RD, et al. Clinical experience with the use of peripheral vasodilator in oral disorders [J].Int J Oral Maxillofac Surg, 1998, 16(6) : 695-699.

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部